Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Medtech Industry Groups Spend Millions In 2019 Lobbying For Device-Tax Repeal – And Much More

Oct 02 2019

• By Sue Darcey

Capitol_Buildng_Dollars

Related Content

Industry, AJC Duke It Out In Georgia Over Ethylene Oxide Risk

Sep 23 2019

AdvaMed Chair: Another Device Tax Moratorium More Likely Than A Full Repeal

Sep 24 2019

Breakthrough Devices To Get Special US Medicare Reimbursement Under CMS Proposal

Apr 24 2019

Industry Requests Three Additional Safe Harbors Under Anti-Kickback Statutes

Oct 29 2018

Medtech Groups To Blitz Congress Before Expected House Device Tax Vote

Jul 02 2018

AdvaMed's Top Hill Strategist JC Scott Departs; Greg Crist Will Fill Role

Sep 20 2018

Sterilization Facility Shutdowns Could Spell Medical Device Shortage; FDA Urges Firms To Assess 'Downstream Impacts'

Mar 26 2019

Physicians Failing To Disclose Supplier, POD Arrangements Fuel Kickback Concerns, Senators Say

Mar 21 2019

Podcast: MDMA CEO Mark Leahey On Industry's Hot Topics

Mar 18 2019

Additional Topics

United States Policy Lobbying Reimbursement Cybersecurity FDA Regulation Trade Policy Medical Device

More from Policy & Regulation

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window